10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q2 2019

Filing Information

Form Type	10-Q
Accession Number	`0001144204-19-040080`
Period End Date	20190630
Filing Date	20190814
Fiscal Year	2019
Fiscal Period	Q2
XBRL Instance	bpth-20190630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 36 Cash Flow Statement 45 Stockholders Equity 25

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$2.58M	USD	Point-in-time
Cash	`Cash`	$17.11M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$1.00M	USD	Point-in-time
Cash	`Cash`	$5.96M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`PrepaidExpenseCurrent`	$654.00K	USD	Point-in-time
Prepaid drug product for testing	`PrepaidExpenseCurrent`	$332.00K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$803.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$845.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.14M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$18.61M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	680,000.00	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	2.83M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	680,000.00	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	2.83M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$998.00K	USD	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$998.00K	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$691.00K	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$592.00K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$307.00K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$406.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	$407.00K	USD	Point-in-time
Total Assets	`Assets`	$19.32M	USD	Point-in-time
Total Assets	`Assets`	$2.54M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$444.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$587.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$555.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$740.00K	USD	Point-in-time
Current portion of lease liabilities	`OperatingLeaseLiabilityCurrent`	$34.00K	USD	Point-in-time
Current portion of lease liabilities	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.33M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.03M	USD	Point-in-time
Noncurrent lease liabilities	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Noncurrent lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$373.00K	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.41M	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.33M	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 2,831 and 680 shares issued and outstanding, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 2,831 and 680 shares issued and outstanding, respectively	`CommonStockValue`	$1.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$69.62M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$48.96M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-47.74M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-51.71M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$20.14M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$1.22M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$4.74M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$8.07M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$6.28M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$17.91M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$2.54M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$19.32M	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$827.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.76M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.92M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.52M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.09M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.84M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$966.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$852.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.60M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$2.49M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$4.01M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$1.68M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.68M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-4.01M	USD	2 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-2.49M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-3.60M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$5.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$33.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$2.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$41.00K	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$5.00K	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$41.00K	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$33.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$2.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.59M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.68M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.46M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.97M	USD	2 Qtrs
Net loss per share, basic and diluted (in dollars)	`EarningsPerShareBasicAndDiluted`	$-0.87	USD	1 Quarter
Net loss per share, basic and diluted (in dollars)	`EarningsPerShareBasicAndDiluted`	$-2.96	USD	1 Quarter
Net loss per share, basic and diluted (in dollars)	`EarningsPerShareBasicAndDiluted`	$-1.75	USD	2 Qtrs
Net loss per share, basic and diluted (in dollars)	`EarningsPerShareBasicAndDiluted`	$-6.34	USD	2 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.27M	shares	2 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.83M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	567,000.00	shares	2 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	567,000.00	shares	1 Quarter

Cash Flow Statement 45 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.59M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.68M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.46M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.97M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$263.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$338.00K	USD	2 Qtrs
Amortization of technology license	`AmortizationOfIntangibleAssets`	$80.00K	USD	2 Qtrs
Amortization of technology license	`AmortizationOfIntangibleAssets`	-	USD	2 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetsAmortization`	-	USD	2 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetsAmortization`	$56.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$99.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$132.00K	USD	2 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$215.00K	USD	2 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$322.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$251.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$42.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$214.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-328.00K	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$56.00K	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	-	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.22M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.37M	USD	2 Qtrs
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	2 Qtrs
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$17.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-17.00K	USD	2 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.50M	USD	Point-in-time
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$19.41M	USD	2 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$17.00M	USD	Point-in-time
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$900.00K	USD	Point-in-time
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromStockOptionsExercised`	$914.00K	USD	2 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromStockOptionsExercised`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$20.32M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	2 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.39M	USD	2 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$16.10M	USD	2 Qtrs
Cash, beginning of period	`Cash`	$2.58M	USD	Point-in-time
Cash, beginning of period	`Cash`	$17.11M	USD	Point-in-time
Cash, beginning of period	`Cash`	$1.00M	USD	Point-in-time
Cash, beginning of period	`Cash`	$5.96M	USD	Point-in-time
Cash, end of period	`Cash`	$2.58M	USD	Point-in-time
Cash, end of period	`Cash`	$17.11M	USD	Point-in-time
Cash, end of period	`Cash`	$1.00M	USD	Point-in-time
Cash, end of period	`Cash`	$5.96M	USD	Point-in-time

Stockholders Equity 25 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$20.14M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$1.22M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$4.74M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$8.07M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$6.28M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$17.91M	USD	Point-in-time
Issuance of common stock, net of fees	`StockIssuedDuringPeriodValueNewIssues`	$19.41M	USD	2 Qtrs
Issuance of common stock, net of fees	`StockIssuedDuringPeriodValueNewIssues`	$1.70M	USD	Point-in-time
Issuance of common stock, net of fees (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	648,233.00	shares	Point-in-time
Exercise of warrants, net of fees	`StockIssueDuringPeriodValueWarrantsExercised`	$45.00K	USD	1 Quarter
Exercise of warrants, net of fees	`StockIssueDuringPeriodValueWarrantsExercised`	$914.00K	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$181.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$338.00K	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$139.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$263.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.59M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.68M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.46M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.97M	USD	2 Qtrs
Ending Balance	`StockholdersEquity`	$20.14M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$1.22M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$4.74M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$8.07M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$6.28M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$17.91M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.